• 1. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 2. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

3-(4-Acetoxyphenyl)-2-bromo-1-propene: A Comprehensive Overview

3-(4-Acetoxyphenyl)-2-bromo-1-propene, also known by its CAS number 890097-87-7, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound is characterized by its unique structure, which includes a bromine atom at the second position of a propene chain and an acetoxyphenyl group attached at the third position. The acetoxyphenyl group, specifically the 4-acetoxyphenyl moiety, contributes to the compound's aromaticity and potential biological activity.

The synthesis of 3-(4-Acetoxyphenyl)-2-bromo-1-propene involves a series of well-established organic reactions. Typically, the starting material is a substituted styrene, which undergoes bromination to introduce the bromine atom at the desired position. The acetoxy group is introduced through an acetylation reaction, often using acetic anhydride in the presence of a suitable catalyst. The optimization of these reaction conditions has been a focus of recent studies to enhance yield and purity.

Recent research has highlighted the potential of 3-(4-Acetoxyphenyl)-2-bromo-1-propene as a precursor in the synthesis of bioactive molecules. For instance, studies have shown that this compound can undergo various transformations, such as elimination reactions or nucleophilic substitutions, to yield products with promising pharmacological properties. One notable application is its use in the development of anti-inflammatory agents, where the bromine atom plays a critical role in modulating the compound's activity.

The physical and chemical properties of 3-(4-Acetoxyphenyl)-2-bromo-1-propene have been extensively characterized. It has a melting point of approximately 65°C and a boiling point around 150°C under standard conditions. The compound is sparingly soluble in water but exhibits good solubility in organic solvents such as dichloromethane and ethyl acetate. These properties make it suitable for various synthetic applications requiring controlled solubility profiles.

In terms of stability, 3-(4-Acetoxyphenyl)-2-bromo-1-propene is relatively stable under normal storage conditions. However, exposure to strong oxidizing agents or prolonged heating can lead to decomposition. Recent studies have explored the use of stabilizing agents to enhance its shelf life without compromising its reactivity in synthetic processes.

The biological activity of 3-(4-Acetoxyphenyl)-2-bromo-1-propene has been a focal point of recent investigations. Preclinical studies suggest that this compound exhibits moderate anti-proliferative activity against certain cancer cell lines. The acetoxyphenyl group is believed to contribute to this activity by enhancing the compound's ability to interact with cellular targets such as kinases or receptors.

In conclusion, 3-(4-Acetoxyphenyl)-2-bromo-1-propene, with its CAS number 890097-87-7, represents a valuable building block in organic synthesis and drug discovery. Its unique structure, coupled with its versatile reactivity and promising biological properties, positions it as a key compound for future research and development in the pharmaceutical industry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)